|
ИСТИНА |
Войти в систему Регистрация |
ИПМех РАН |
||
Magnetohydrodynamic thermochemotherapy and MRI of malignant tumors oncogenesisстатья
Информация о цитировании статьи получена из
Web of Science
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 15 ноября 2012 г.
- Авторы: Brusentsov N.A., Pirogov Y.A., Polyanskiy V.A., Anisimov N.V., Golubeva I.S., Gulyaev M.V., Nikitin M.P., Yuriev M.V., Brusentsova T.N., Nikitin P.I.
- Журнал: Journal of Magnetism and Magnetic Materials
- Год издания: 2011
- Издательство: Elsevier BV
- Местоположение издательства: Netherlands
- Первая страница: 717
- Последняя страница: 720
- Аннотация: Abstract: Citric-ferrite sol (CFS) has been synthesized and successfully tested as MRI negative contrast preparation for revealing primary tumors, and also invasions and metastases at the tumor relapses. Magnetohydrodynamic thermochemotherapy (MTC) by Cysplatin (CP), Mitoxantron (MX), Melphalan (MP) combined with CFS, which were carefully monitoring in vivo and quantified by an electronic detector, improved results of cancer treatment. At various stages of oncogenesis, MTC with CFS at a dose of 62 mg Fe/kg combined with chemotherapeutic drugs was performed at +48º C for 30 min. While such MTC, treatment of ~30 mm3 B 16 melanoma tumor by AC magnetic field led to tumor regression in female mice up to 40 %, and an increase of life span up to 300 % was achieved.
- Добавил в систему: Бердалин Александр Берикович